Klaus Maisinger

USPTO Granted Patents = 12 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 8.6

ph-index = 5

Forward Citations = 276(Granted Patents)

Location History:

Nr Saffron Walden, GB (2020)
Cambridge, GB (2012 - 2023)
Essex, GB (2015 - 2023)

Company Filing History:

Illumina Cambridge Limited

patents

Years Active: 2012-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12385092 - Methods and arrays for producing and sequencing monoclonal clusters of nucleic acid (2025-08-12),

2. 12380561 - Creating a template of nucleic acid site locations on a flow cell (2025-08-05),

3. 12307670 - Analyzing image data from nucleic acid sequencing (2025-05-20),

4. 12223651 - Identifying nucleotides by determining phasing (2025-02-11),

5. 11692223 - Methods and arrays for producing and sequencing monoclonal clusters of nucleic acid (2023-07-04),

6. 11676275 - Identifying nucleotides by determining phasing (2023-06-13),

7. 11605165 - System and methods for identifying nucleotides (2023-03-14),

8. 10619204 - Methods and arrays for producing and sequencing monoclonal clusters of nucleic acid (2020-04-14),

9. 10304189 - Data processing system and methods (2019-05-28),

10. 9530207 - Data processing system and methods (2016-12-27),

11. 8965076 - Data processing system and methods (2015-02-24),

12. 8241573 - Systems and devices for sequence by synthesis analysis (2012-08-14),

Title: Inventor Klaus Maisinger: Innovating DNA Sequencing Technologies

Introduction

Klaus Maisinger, a prominent inventor based in Essex, GB, has made significant contributions to the field of DNA sequencing. With a portfolio of eight patents, his work focuses on enhancing methodologies for analyzing image data generated during nucleic acid sequencing. His innovations are aimed at improving the efficiency and accuracy of genetic analysis.

Latest Patents

Among his latest patents are innovative methodologies for analyzing image data from nucleic acid sequencing. Specifically, he has developed methods and systems that facilitate real-time analysis of image and sequence data generated during DNA sequencing methodologies. His focus on identifying nucleotides through phasing further contributes to enhancing the reliability of DNA sequencing processes.

Career Highlights

Klaus Maisinger is a valuable team member at Illumina Corporation, a leader in the field of genomic analysis. His expertise in developing advanced analysis techniques has positioned him as a key figure in the progressing field of biotechnology. With a total of eight patents, his contributions reflect a dedication to scientific advancement and a commitment to improving genetic research.

Collaborations

Throughout his career, Klaus has collaborated with prominent colleagues, including Stephen Tanner and John A Moon. These partnerships have enriched his work and have led to significant advancements in the methodologies and technologies related to DNA sequencing.

Conclusion

Klaus Maisinger's innovative work in DNA sequencing technologies showcases his expertise and dedication to the field. His patents not only advance the scientific community but also have the potential to drive further research and development in genomics. As the field continues to evolve, his contributions will undoubtedly play a crucial role in shaping the future of genetic analysis.

This text is generated by artificial intelligence and may not be accurate.